Recombinant Influenza A Virus H5N1 Neuraminidase Protein, CF

Images

 
There are currently no images for Neuraminidase (7597-NM).

Every product we sell is backed by Novus' 100% Guarantee. If you have used this product, please submit your images and reviews to earn reward points.

Product Details

Summary
Reactivity VSpecies Glossary
Applications Enzyme Activity
Format
Carrier-Free

Order Details

Recombinant Influenza A Virus H5N1 Neuraminidase Protein, CF Summary

Details of Functionality
Measured by its ability to cleave a fluorogenic substrate, 2’-(4-Methylumbelliferyl)-alpha -D-N-acetylneuraminic acid. The specific activity is >2,500 pmol/min/μg, as measured under the described conditions.
Source
Mouse myeloma cell line, NS0-derived influenza a virus h5n1 Viral Neuraminidase protein
Ser37-Lys449, with an N-terminal vasodilator-stimulated phosphoprotein tetramerization domain and a C-terminal 6-His tag
Accession #
N-terminal Sequence
Ser (tetramerization domain)
Protein/Peptide Type
Recombinant Enzymes
Purity
>95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain at 5 μg per lane
Endotoxin Note
<0.10 EU per 1 μg of the protein by the LAL method.

Applications/Dilutions

Theoretical MW
51 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
SDS-PAGE
58-65 kDa, reducing conditions
Publications
Read Publication using
7597-NM in the following applications:

Packaging, Storage & Formulations

Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.
Buffer
Supplied as a 0.2 μm filtered solution in Tris, NaCl and Glycerol.
Purity
>95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain at 5 μg per lane
Assay Procedure
  • Activation Buffer: 50 mM MES, 500 mM NaCl, 30 mM CaCl2, pH 6.5
  • Assay Buffer: 50 mM MES, 500 mM NaCl, 5 mM CaCl2, pH 6.5
  • Recombinant Influenza A Virus H5N1 Neuraminidase (rvH5N1 Neuraminidase) (Catalog # 7597-NM)
  • Substrate: 4-Methylumbelliferyl-alpha -D-N-acetylneuraminic acid (Sigma, Catalog # M8639), 10 mM stock  in DMSO
  • F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
  • Fluorescent Plate Reader (Model: Gemini EM by Molecular Devices) or equivalent
  1. Dilute rvH5N1 Neuraminidase to 100 μg/mL in Activation Buffer.
  2. Incubate for 24 hours at 37 °C to activate.
  3. Dilute activated rvH5N1 Neuraminidase to 0.5 ng/μL in Assay Buffer.
  4. Dilute Substrate to 400 µM in Assay Buffer.
  5. Load into a black well plate 50 µL of the 0.5 ng/μL rvH5N1 Neuraminidase and start the reaction by adding 50 µL of 400 µM Substrate. Include a Substrate Blank containing Assay Buffer in place of rvH5N1 Neuraminidase.
  6. Read at excitation and emission wavelengths of 365 nm and 445 nm (top read), respectively, in kinetic mode for 5 minutes.
  7. Calculate specific activity:

         Specific Activity (pmol/min/µg) =

    Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU)
    amount of enzyme (µg)

     *Adjusted for Substrate Blank
     **Derived using calibration standard 4-Methylumbelliferone (Sigma, Catalog # M1381).

Per Well:
  • rvH5N1 Neuraminidase: 0.025 µg
  • Substrate: 200 µM

Notes

Coomassie is a registered trademark of Imperial Chemical Industries Ltd.

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Recombinant Influenza A Virus H5N1 Neuraminidase Protein, CF

  • NANH
  • Viral Neuraminidase

Background

Neuraminidase (NA) and hemagglutinin (HA) are the two predominant membrane glycoproteins found on the surface of an influenza virus particle. They are essential for the infectious cycle of the virus. HA recognizes and binds to the sialic acid on the host cell membrane to initiate a viral infection. NA cleaves the sialic acid at the end of the cycle, allowing the progeny virus to leave the host and initiate the next round of infection (1). In the early stage of an infection, NA may also assist in viral penetration of the mucus layer in the airway of a host. Nine subtypes of NA (N1 to N9) have been identified, all of which are believed to be tetrameric and share a basic structure consisting of a globular head, a thin stalk region, and a small hydrophobic region that anchors the protein in the virus membrane (2). Glycosylation has also found been important for the stability and activity of these enzymes (3, 4). According to a recent structure determination (5), there are two genetically distinct groups of neuraminidases from influenza type A viruses, with the N1 and N2 neuraminidases representing the two groups. Due to their critical role in the infectious cycle of a virus, influenza viral neuraminidases are frequently used as targets for drug design. In fact, both Tamiflu and Relenza, anti-influenza drugs, are neuraminidase inhibitors. Our recombinant H5N1 neuraminidase is based on the avian virus isolated from the 2004 outbreaks of the H5N1 virus in Vietnam and Thailand (6). H5N1 avian virus is one of the most lethal viruses in history (7, 8) with an accumulative death rate of 59% from 2003 to 2012 according to the World Health Organization (9). To produce active recombinant enzyme, a tetramerization domain from the vasodilator-stimulated phosphoprotein (10) was inserted at the N‑terminus to assist in oligomerization of the protein. We found that the activity of the recombinant H5N1 neuraminidase is activated by Ca2+ and inactivated by Zn2+, Cu2+ and Fe2+.
  1. Palese, P. & Compans, R. W. (1976) J. Gen. Virol. 33:159.
  2. Colman, P. M. et al. (1983) Nature 303:41.
  3. Wu, Z.L. et al. (2009) Biochem. Biophys. Res. Commun. 379:749.
  4. Sun, S. et al. (2012) PLoS one 7:e32119.
  5. Russell, R.J. et al. (2006) Nature 443:45.
  6. Govorkova, E.A. et al. (2005) J. Virol. 79:2191.
  7. Ducatez, M.F. et al. (2006) Nature 442:37.
  8. Peiris, J.S. et al. (2007) Clin. Microbiol. Rev. 20:243.
  9. http://www.who.int/influenza/human_animal_interface/EN_GIP_20120405NCumulativeNumberH5N1cases.pdf
  10. Kuhnel, K. et al. (2004) Proc. Natl. Acad. Sci. U. S. A. 101:17027.

Publications for Neuraminidase (7597-NM)(1)

We have publications tested in 1 confirmed species: Mouse.

We have publications tested in 1 application: Western Blot Control.


Filter By Application
Western Blot Control
(1)
All Applications
Filter By Species
Mouse
(1)
All Species

Reviews for Neuraminidase (7597-NM) (0)

There are no reviews for Neuraminidase (7597-NM). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen

FAQs for Neuraminidase (7597-NM) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.

Other Available Formats

Additional Neuraminidase Products

Blogs on Neuraminidase

There are no specific blogs for Neuraminidase, but you can read our latest blog posts.

Contact Information

Product PDFs

Calculators

Concentration Calculator

The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.

=
÷

Review this Product

Be the first to review our Recombinant Influenza A Virus H5N1 Neuraminidase Protein, CF and receive a gift card or discount.

Bioinformatics

Uniprot